Thomas Drivsholm

2.9k total citations
43 papers, 2.2k citations indexed

About

Thomas Drivsholm is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Thomas Drivsholm has authored 43 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Thomas Drivsholm's work include Pancreatic function and diabetes (12 papers), Metabolism, Diabetes, and Cancer (11 papers) and Adipose Tissue and Metabolism (9 papers). Thomas Drivsholm is often cited by papers focused on Pancreatic function and diabetes (12 papers), Metabolism, Diabetes, and Cancer (11 papers) and Adipose Tissue and Metabolism (9 papers). Thomas Drivsholm collaborates with scholars based in Denmark, United Kingdom and Sweden. Thomas Drivsholm's co-authors include Oluf Pedersen, Knut Borch‐Johnsen, Torben Hansen, K. Borch‐Johnsen, Gary L. Andersen, Søren A. Urhammer, Jakob Ek, Bendix Carstensen, Michael Davidsen and Hans Ibsen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Thomas Drivsholm

43 papers receiving 2.1k citations

Peers

Thomas Drivsholm
Wing Yee So Hong Kong
Srikanth Bellary United Kingdom
Errol D. Crook United States
Fernando Ovalle United States
James R. Gavin United States
Soon Jib Yoo South Korea
Wing Yee So Hong Kong
Thomas Drivsholm
Citations per year, relative to Thomas Drivsholm Thomas Drivsholm (= 1×) peers Wing Yee So

Countries citing papers authored by Thomas Drivsholm

Since Specialization
Citations

This map shows the geographic impact of Thomas Drivsholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Drivsholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Drivsholm more than expected).

Fields of papers citing papers by Thomas Drivsholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Drivsholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Drivsholm. The network helps show where Thomas Drivsholm may publish in the future.

Co-authorship network of co-authors of Thomas Drivsholm

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Drivsholm. A scholar is included among the top collaborators of Thomas Drivsholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Drivsholm. Thomas Drivsholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sørensen, Grith Lykke, Else‐Marie Bladbjerg, Rudi Steffensen, et al.. (2015). Association between the surfactant protein D (SFTPD) gene and subclinical carotid artery atherosclerosis. Atherosclerosis. 246. 7–12. 15 indexed citations
2.
Olivarius, Niels de Fine, Volkert Siersma, Beatrice Dyring‐Andersen, et al.. (2010). Patients Newly Diagnosed with Clinical Type 2 Diabetes during Oral Glucocorticoid Treatment and Observed for 14 Years: All‐Cause Mortality and Clinical Developments. Basic & Clinical Pharmacology & Toxicology. 108(4). 285–288. 3 indexed citations
3.
Gorter, Kees J., Johan Wens, Kamlesh Khunti, et al.. (2010). The European EUCCLID pilot study on care and complications in an unselected sample of people with type 2 diabetes in primary care. Primary care diabetes. 4(1). 17–23. 8 indexed citations
4.
Pociot, Flemming, Søren K. Paulsen, K. Borch‐Johnsen, et al.. (2006). Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance. Genes and Immunity. 7(4). 316–321. 22 indexed citations
5.
Rose, C S, Gary L. Andersen, Charlotte Glümer, et al.. (2005). Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion. Diabetic Medicine. 22(7). 946–949. 12 indexed citations
6.
Drivsholm, Thomas & Niels de Fine Olivarius. (2005). Routine diagnosis of Type 2 diabetes mellitus in general practice and hospitals: how do patients differ?. Diabetic Medicine. 22(3). 336–339. 3 indexed citations
7.
Hansen, Sara K., Eva-Maria D. Nielsen, Jakob Ek, et al.. (2005). Analysis of Separate and Combined Effects of Common Variation in KCNJ11 and PPARG on Risk of Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3629–3637. 49 indexed citations
8.
Andersen, Gary L., Lise Wegner, K. Yanagisawa, et al.. (2005). Evidence of an association between genetic variation of the coactivator PGC-1β and obesity. Journal of Medical Genetics. 42(5). 402–407. 44 indexed citations
9.
Hansen, Lars J., Niels de Fine Olivarius, Volkert Siersma, Thomas Drivsholm, & John Sahl Andersen. (2004). Individualised treatment goals in diabetes care. Scandinavian Journal of Primary Health Care. 22(2). 71–77. 10 indexed citations
10.
Hansen, Sara K., Anette P. Gjesing, Søren K. Rasmussen, et al.. (2004). Large-scale studies of the HphI insulin gene variable-number-of-tandem-repeats polymorphism in relation to Type 2 diabetes mellitus and insulin release. Diabetologia. 47(6). 1079–87. 40 indexed citations
11.
Johansen, Anders, Gary L. Andersen, Thomas Drivsholm, et al.. (2004). Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion. Diabetologia. 47(8). 1437–41. 26 indexed citations
12.
Dalgaard, Louise T., Gary L. Andersen, Lesli H. Larsen, et al.. (2003). Mutational Analysis of the UCP2 Core Promoter and Relationships of Variants with Obesity. Obesity Research. 11(11). 1420–1427. 46 indexed citations
13.
Maat, Moniek P.M. de, et al.. (2003). Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. Journal of Thrombosis and Haemostasis. 1(5). 950–957. 55 indexed citations
14.
Balkau, Beverley, Marie‐Aline Charles, Thomas Drivsholm, et al.. (2002). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome.. PubMed. 28(5). 364–76. 411 indexed citations
15.
Hansen, Lars J. & Thomas Drivsholm. (2002). [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].. PubMed. 164(5). 607–9. 8 indexed citations
16.
Ek, Jakob, Gary L. Andersen, Søren A. Urhammer, et al.. (2001). Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia. 44(12). 2220–2226. 242 indexed citations
18.
Drivsholm, Thomas, Hans Ibsen, Marianne Schroll, Michael Davidsen, & K. Borch‐Johnsen. (2001). Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60‐year‐old Danes. Diabetic Medicine. 18(2). 126–132. 108 indexed citations
19.
Møller, Ann Merete, Niels Melchior Jensen, Julie Pildal, et al.. (2001). Studies of Genetic Variability of the Glucose Transporter 2 Promoter in Patients with Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 86(5). 2181–2186. 19 indexed citations
20.
Dalgaard, Louise T., Thorkild I. A. Sørensen, Thomas Drivsholm, et al.. (2001). A Prevalent Polymorphism in the Promoter of theUCP3Gene and Its Relationship to Body Mass Index and Long Term Body Weight Change in the Danish Population1. The Journal of Clinical Endocrinology & Metabolism. 86(3). 1398–1402. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026